BG97221A - Ортозаместени бифениламидини и бифенилизанидини и съдържащите ги антидиабетични или хипогликемични средства - Google Patents
Ортозаместени бифениламидини и бифенилизанидини и съдържащите ги антидиабетични или хипогликемични средства Download PDFInfo
- Publication number
- BG97221A BG97221A BG097221A BG9722192A BG97221A BG 97221 A BG97221 A BG 97221A BG 097221 A BG097221 A BG 097221A BG 9722192 A BG9722192 A BG 9722192A BG 97221 A BG97221 A BG 97221A
- Authority
- BG
- Bulgaria
- Prior art keywords
- carbon atoms
- group
- optionally substituted
- formula
- carbon
- Prior art date
Links
- 230000003178 anti-diabetic effect Effects 0.000 title 1
- 239000003472 antidiabetic agent Substances 0.000 title 1
- 239000003795 chemical substances by application Substances 0.000 title 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 18
- 125000000217 alkyl group Chemical group 0.000 abstract 6
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical group N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract 3
- 125000003545 alkoxy group Chemical group 0.000 abstract 3
- 125000002947 alkylene group Chemical group 0.000 abstract 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 3
- 229910052757 nitrogen Inorganic materials 0.000 abstract 3
- 125000001931 aliphatic group Chemical group 0.000 abstract 2
- 125000000623 heterocyclic group Chemical group 0.000 abstract 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 1
- 125000004414 alkyl thio group Chemical group 0.000 abstract 1
- 125000003277 amino group Chemical group 0.000 abstract 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
- 125000001589 carboacyl group Chemical group 0.000 abstract 1
- 150000001721 carbon Chemical group 0.000 abstract 1
- 229910052799 carbon Chemical group 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 abstract 1
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
- 125000004076 pyridyl group Chemical group 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000000475 sulfinyl group Chemical group [*:2]S([*:1])=O 0.000 abstract 1
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 abstract 1
- 229910052717 sulfur Inorganic materials 0.000 abstract 1
- 239000011593 sulfur Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C257/00—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines
- C07C257/10—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines
- C07C257/14—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines having carbon atoms of amidino groups bound to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C257/00—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines
- C07C257/10—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines
- C07C257/16—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines having carbon atoms of amidino groups bound to carbon atoms of rings other than six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C261/00—Derivatives of cyanic acid
- C07C261/04—Cyanamides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C279/18—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to carbon atoms of six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/26—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C317/32—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/26—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C317/32—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
- C07C317/34—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having sulfone or sulfoxide groups and amino groups bound to carbon atoms of six-membered aromatic rings being part of the same non-condensed ring or of a condensed ring system containing that ring
- C07C317/38—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having sulfone or sulfoxide groups and amino groups bound to carbon atoms of six-membered aromatic rings being part of the same non-condensed ring or of a condensed ring system containing that ring with the nitrogen atom of at least one amino group being part of any of the groups, X being a hetero atom, Y being any atom, e.g. N-acylaminosulfones
- C07C317/42—Y being a hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C323/39—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
- C07C323/43—Y being a hetero atom
- C07C323/44—X or Y being nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/12—Oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/42—Oxygen atoms attached in position 3 or 5
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/44—Nitrogen atoms not forming part of a nitro radical
- C07D233/50—Nitrogen atoms not forming part of a nitro radical with carbocyclic radicals directly attached to said nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
- C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/13—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
- C07D295/215—Radicals derived from nitrogen analogues of carbonic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
- C07D295/26—Sulfur atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Steroid Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pyridine Compounds (AREA)
- Saccharide Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
1. Съединения с формулаи техните фармацевтично приемливи соли, в която формула R1 е фенил, по избор заместен с халоген, алкил с 1 до 3 въглеродни атома, алкокси с 1 до 3 въглеродниатома, алканоил с 2 до 4 въглеродни атома или група с формула S(0)nR8, в коятоn има стойност 0 или 1, R8 e алкилова група с 1 до 3 въглеродни атома, R2 - група с формулав която R6 и R7, които са еднакви или различни, са Н или алкилова група, съдържаща 1 до 4 въглеродни атома, R3 e Н или алифатна група с линейна, или разклонена верига с 1 до 4 въглеродни атома, R4 е: а) Н; б) алифатна група с линейна или разклонена верига с 1 до 6 въглеродни атома, по избор заместена с хидрокси или негово ацилирано производно, с алкоксигрупа, съдържаща 1 до 3 въглеродни атома, с алкилтиогрупа, съдържаща 1 до 3 въглеродни атома, по избор с алкилирана аминогрупа, с въглероден пръстен, съдържащ 3 до 7 въглеродни атома, с пиридил илис циано; в) въглероден пръстен, съдържащ до 7 въглеродни атома и по избор заместен с хидрокси при условие, че когато R3, R4, R6 са R7, не са всичките метил, когато R1 e фенил; или групата R2 и R3 заедно с азотния и въглеродния атом, къмкоито са свързани, образуват хетероцикличен пръстен с формулав която R4 има посочените значения, с изключение на това, че R4 не може да бъде Н и R11 е Н, или алкилова група, съдържаща 1 или 2 въглеродни атома, и Е е алкиленова група с 2 до 4 въглеродни атома, по избор заместена с една или повече алкилови групи, съдържащи 1 до 3 въглеродни атома; или R3 и R4 заедно с азотнияатом, към който са свързани, образуват тероцикличен пръстен с формулав която G е алкиленова група с 4 до 6 въглеродни атома, по избор прекъсната откислород, сяра, сулфинилова и сулфонилова група или азот, по избор заместени с: а) въглероден пръстен, съдържащ 3 до 7 въглеродни атома; б) метилсулфонилова група или в) алкилова група, съдържаща 1 до 3 въглеродни атома, и по избор заместени с хидрокси- или алкоксигрупа, съдържаща 1 до 3 въглеродни атома, а алкиленовата група е заместена
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN126BO1990 IN172842B (bg) | 1990-05-17 | 1990-05-17 | |
GB909014456A GB9014456D0 (en) | 1990-06-28 | 1990-06-28 | Therapeutic agents |
PCT/EP1991/000911 WO1992000273A1 (en) | 1990-05-17 | 1991-05-15 | Orthosubstituted biphenyl amidine and biphenyl guanidine derivatives and antidiabetic or hypoglycaemic agents containing them |
Publications (2)
Publication Number | Publication Date |
---|---|
BG97221A true BG97221A (bg) | 1993-12-24 |
BG61260B1 BG61260B1 (en) | 1997-04-30 |
Family
ID=26297257
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BG97221A BG61260B1 (en) | 1990-05-17 | 1992-12-22 | Orthosubstituted biphenyl amidine and biphenyl guanidinederivatives and antidiabetic or hypoglycamic agents containingthem |
Country Status (27)
Country | Link |
---|---|
US (1) | US5302720A (bg) |
EP (1) | EP0536151B1 (bg) |
JP (1) | JPH089589B2 (bg) |
KR (1) | KR920005714A (bg) |
CN (1) | CN1028521C (bg) |
AT (1) | ATE111445T1 (bg) |
AU (1) | AU637695B2 (bg) |
BG (1) | BG61260B1 (bg) |
CA (1) | CA2041846A1 (bg) |
CZ (1) | CZ280182B6 (bg) |
DE (1) | DE69104041T4 (bg) |
DK (1) | DK0536151T3 (bg) |
ES (1) | ES2064103T3 (bg) |
FI (1) | FI95566C (bg) |
GB (1) | GB2244486B (bg) |
HR (1) | HRP930699A2 (bg) |
HU (1) | HU210200B (bg) |
IE (1) | IE64485B1 (bg) |
IL (1) | IL98029A (bg) |
IN (1) | IN172842B (bg) |
MX (1) | MX25770A (bg) |
NO (1) | NO179204C (bg) |
NZ (1) | NZ238119A (bg) |
PL (1) | PL167657B1 (bg) |
PT (1) | PT97700B (bg) |
RU (1) | RU2099323C1 (bg) |
WO (1) | WO1992000273A1 (bg) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU671071B2 (en) * | 1990-08-30 | 1996-08-15 | State of Oregon, acting by and through The Oregon State Board of Higher Education, acting for and on behalf of The Oregon Health Sciences University, Portland, Oregon, and The University of Oregon, Eugene, Oregon, Johnson Hall, | Substituted amidines having high binding to the sigma receptor and the use thereof |
US5298657A (en) * | 1992-03-20 | 1994-03-29 | Cambridge Neuroscience Inc. | Preparation of substituted guanidines |
US5885985A (en) * | 1993-03-23 | 1999-03-23 | Astra Aktiebolag | Guanidine derivatives useful in therapy |
US5512596A (en) * | 1994-09-02 | 1996-04-30 | Gilead Sciences, Inc. | Aromatic compounds |
AU4176396A (en) * | 1994-12-08 | 1996-06-26 | Knoll Aktiengesellschaft | Use of substituted phenylamidine and phenylguanidine compounds for the treatment of cerebral and cardiac ischaemia, convulsion and sickle cell anaemia |
PT805153E (pt) * | 1996-04-30 | 2002-03-28 | Pfizer | Novos agonistas do receptor muscarinico |
US6756389B2 (en) * | 1996-08-09 | 2004-06-29 | Cambridge Neuroscience, Inc. | Pharmaceutically active compounds and methods of use |
KR19990017013A (ko) * | 1997-08-20 | 1999-03-15 | 윤종용 | 가변단속주기의 오디오신호 발생장치 |
DE19737463A1 (de) * | 1997-08-28 | 1999-03-04 | Hoechst Marion Roussel De Gmbh | Verwendung von Inhibitoren des Natrium-Wasserstoff-Austauschers zur Herstellung eines Arzneimittels zur Behandlung von Erkrankungen, die durch Protozoen verursacht werden |
EP1083822A4 (en) | 1998-06-11 | 2005-10-12 | S P O Medical Equipment Ltd | DEVICE FOR DETECTING PHYSIOLOGICAL STRESS AND RELATED METHOD |
HUP0301661A3 (en) * | 2000-07-24 | 2003-11-28 | Bayer Cropscience Ag | Biphenyl carboxamides |
US6992098B2 (en) | 2000-07-24 | 2006-01-31 | Bayer Cropscience Ag | Pyrazolyl biphenyl carboxamides and the use thereof for controlling undesired microorganisms |
DE10258314A1 (de) * | 2002-12-13 | 2004-06-24 | Bayer Cropscience Ag | Biphenyloximether |
PE20070341A1 (es) * | 2005-07-29 | 2007-04-13 | Wyeth Corp | Derivados de pirrol como moduladores del receptor de progesterona |
PE20070182A1 (es) * | 2005-07-29 | 2007-03-06 | Wyeth Corp | Derivados cianopirrol-fenil amida como moduladores del receptor de progesterona |
BRPI0615542B1 (pt) | 2005-09-13 | 2016-04-19 | Bayer Cropscience Ag | composto derivado de fenil-amidina, processos para a preparação de um composto, método para o controle de fungos fitopatogênicos de culturas e método para o controle de insetos nocivos |
CN104945287B (zh) * | 2015-06-12 | 2017-06-13 | 苏州大学张家港工业技术研究院 | 一种脒的磺酸内盐化合物的合成方法 |
AR101498A1 (es) * | 2015-08-11 | 2016-12-21 | Chemo Res S L | Procedimiento para la preparación del compuesto n-(3,5-dimetilfenil)-n-(2-trifluorometilfenil)guanidina y su forma cristalina a |
GB201809295D0 (en) | 2018-06-06 | 2018-07-25 | Institute Of Cancer Res Royal Cancer Hospital | Lox inhibitors |
GB201818750D0 (en) | 2018-11-16 | 2019-01-02 | Institute Of Cancer Res Royal Cancer Hospital | Lox inhibitors |
Family Cites Families (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1850682A (en) * | 1927-01-10 | 1932-03-22 | Ig Farbenindustrie Ag | Substituted guanidines |
GB614072A (en) * | 1946-07-01 | 1948-12-09 | Boots Pure Drug Co Ltd | Manufacture of phenanthridine compounds |
NL299929A (bg) * | 1962-10-30 | |||
US3252982A (en) * | 1963-10-16 | 1966-05-24 | Ciba Geigy Corp | Benzhydryl compounds |
US3669974A (en) * | 1971-03-25 | 1972-06-13 | Usv Pharma Corp | N,n1-disubstituted benzamidines |
BE788767A (fr) * | 1971-09-13 | 1973-01-02 | Richardson Merrell Inc | Compositions hypoglycemiques contenant des derives de benzhydryllactamimide |
FR2223361B1 (bg) * | 1973-03-27 | 1977-04-29 | Philagro Sa | |
DE2417669A1 (de) * | 1974-04-11 | 1975-10-16 | Hoechst Ag | Verfahren zur herstellung von n(halogenaryl)-n',n'-dialkylamidinen |
US4061746A (en) * | 1976-04-23 | 1977-12-06 | Richardson-Merrell Inc. | Lactamimide inhibitors of gastrointestinal hypersecretion |
JPS604829B2 (ja) * | 1977-03-28 | 1985-02-06 | 日本曹達株式会社 | イミダゾール誘導体、その製造方法及び農園芸用殺菌剤 |
US4101659A (en) * | 1977-08-29 | 1978-07-18 | Mcneil Laboratories, Incorporated | Benzhydryl guanidines |
US4414211A (en) * | 1978-09-18 | 1983-11-08 | Mcneilab, Inc. | Heterocyclic derivatives of guanidine |
NL7810350A (nl) * | 1978-10-16 | 1980-04-18 | Duphar Int Res | Preparaat met groeiregulerende werking en gebruik van dit preparaat in land- en tuinbouw. |
CA1138451A (en) * | 1979-04-03 | 1982-12-28 | Ikuo Ueda | 2-imidazoline derivatives, process for the preparation thereof and the pharmaceutical composition of the same |
AU538963B2 (en) * | 1979-07-09 | 1984-09-06 | Seth Thomas Shaw Jr. | Drug for use with an iud |
US4281004A (en) * | 1980-03-31 | 1981-07-28 | Pfizer Inc. | Phenylguanidine therapeutic agents |
DE3108564A1 (de) * | 1981-03-06 | 1982-11-18 | Bayer Ag, 5090 Leverkusen | N-tert-butyl-phenyl-n'-cyclohexyl-quanidine, verfahren zu ihrer herstellung sowie ihre verwendung als fungizide |
EP0073971B1 (en) * | 1981-08-24 | 1986-05-21 | Merck & Co. Inc. | Thiadiazole oxides as gastric antisecretory agents |
DE3220828A1 (de) * | 1982-06-03 | 1983-12-08 | Hoechst Ag, 6230 Frankfurt | Bisamidin-derivate von dephenyl, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel |
IN158084B (bg) * | 1982-06-25 | 1986-08-30 | Council Scient Ind Res | |
DE3343815A1 (de) * | 1983-12-03 | 1985-06-13 | Hoechst Ag, 6230 Frankfurt | Neue bisamidindiphenylderivate, ein verfahren zu ihrer herstellung und ihre verwendung als chemotherapeutika |
US4680300A (en) * | 1985-01-10 | 1987-07-14 | Syntex (U.S.A.) Inc. | Anti-inflammatory guanidines |
US4781866A (en) * | 1985-03-15 | 1988-11-01 | Mcneilab, Inc. | Process for producing amidine sulfonic acid intermediates for guanidines |
US4656270A (en) * | 1985-03-15 | 1987-04-07 | Mcneilab, Inc. | Process for producing guanidines such as linogliride |
US4693850A (en) * | 1985-03-15 | 1987-09-15 | Mcneilab, Inc. | Methane sulfonic acid derivatives |
SG47583A1 (en) * | 1986-01-13 | 1998-04-17 | American Cyanamid Co | 4,5,6-Substituted-n- (substituted-phenyl) -2- pyrimidinamines |
US4709094A (en) * | 1986-07-10 | 1987-11-24 | State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon | Sigma brain receptor ligands and their use |
GB8903592D0 (en) * | 1989-02-16 | 1989-04-05 | Boots Co Plc | Therapeutic agents |
IE62023B1 (en) * | 1989-01-02 | 1994-12-14 | Boots Co Plc | Therapeutic agents |
DE3922232A1 (de) * | 1989-07-06 | 1991-01-17 | Basf Ag | Fungizide guanidine |
EP0418199A3 (en) * | 1989-09-13 | 1991-06-12 | Ciba-Geigy Ag | Guanidine derivatives |
-
1990
- 1990-05-17 IN IN126BO1990 patent/IN172842B/en unknown
-
1991
- 1991-04-29 IE IE143991A patent/IE64485B1/en not_active IP Right Cessation
- 1991-05-02 IL IL9802991A patent/IL98029A/en active IP Right Grant
- 1991-05-06 CA CA002041846A patent/CA2041846A1/en not_active Abandoned
- 1991-05-07 CZ CS911334A patent/CZ280182B6/cs not_active IP Right Cessation
- 1991-05-07 AU AU76394/91A patent/AU637695B2/en not_active Ceased
- 1991-05-10 NZ NZ238119A patent/NZ238119A/en unknown
- 1991-05-13 GB GB9110306A patent/GB2244486B/en not_active Expired - Fee Related
- 1991-05-14 MX MX25770A patent/MX25770A/es unknown
- 1991-05-15 AT AT91909161T patent/ATE111445T1/de not_active IP Right Cessation
- 1991-05-15 PL PL91297374A patent/PL167657B1/pl unknown
- 1991-05-15 DK DK91909161.1T patent/DK0536151T3/da active
- 1991-05-15 KR KR1019910007829A patent/KR920005714A/ko not_active Application Discontinuation
- 1991-05-15 RU RU9292016545A patent/RU2099323C1/ru active
- 1991-05-15 EP EP91909161A patent/EP0536151B1/en not_active Expired - Lifetime
- 1991-05-15 JP JP3508950A patent/JPH089589B2/ja not_active Expired - Lifetime
- 1991-05-15 ES ES91909161T patent/ES2064103T3/es not_active Expired - Lifetime
- 1991-05-15 DE DE69104041A patent/DE69104041T4/de not_active Expired - Fee Related
- 1991-05-15 WO PCT/EP1991/000911 patent/WO1992000273A1/en active IP Right Grant
- 1991-05-16 HU HU911650A patent/HU210200B/hu not_active IP Right Cessation
- 1991-05-16 PT PT97700A patent/PT97700B/pt not_active IP Right Cessation
- 1991-11-14 CN CN91110775A patent/CN1028521C/zh not_active Expired - Fee Related
-
1992
- 1992-06-17 US US07/899,939 patent/US5302720A/en not_active Expired - Fee Related
- 1992-12-10 NO NO924783A patent/NO179204C/no unknown
- 1992-12-22 BG BG97221A patent/BG61260B1/bg unknown
- 1992-12-23 FI FI925871A patent/FI95566C/fi active
-
1993
- 1993-04-02 HR HR930699A patent/HRP930699A2/hr not_active Application Discontinuation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BG97221A (bg) | Ортозаместени бифениламидини и бифенилизанидини и съдържащите ги антидиабетични или хипогликемични средства | |
DE3781716D1 (de) | Mittel zur ortsspezifischen alkylierung. | |
CO5070570A1 (es) | DERIVADOS DE TIROSINA COMO ACTIVADORES DE hPPAR Y hPPARalfa Y UNA COMPOSICION FARMACEUTICA QUE LOS CONTIENE | |
LU91196I2 (fr) | Picoxystrobin et ses dérivlés pharmaceutiquement acceptables(ACANTO). | |
KR930703319A (ko) | 키산틴 유도체 | |
ATE107636T1 (de) | Substituierte phenyl-2-propensäure derivate und ihre verwendung als fungizide. | |
DK397988A (da) | Dihydropyridinforbindelser og deres avendelse til fremstilling af et laegemiddel til behandling af alergiske og inflammatoriske tilstande samt farmaceutiske praeparater indeholdende forbindelserne | |
GR3002548T3 (en) | Acrylic acid derivatives and fungicides containing them | |
PT1468692E (pt) | Utilizacao de 2,6-dialquil-4-sililfenois para o tratamento do xantoma | |
NO890440L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive isokinolinderivater. | |
DK677487A (da) | Indanderivater, deres fremstilling og laegemiddel med indhold deraf | |
ES2084120T3 (es) | Medicamentos para prevenir y tratar enfermedades del aparato circulatorio que contienen compuestos de espiro-3-heteroazolidina. | |
IL60443A (en) | 2,2-dichlorocyclopropyl-methylphosphoric acid derivatives,their preparation and their use in combating pests | |
ES2118343T3 (es) | Nuevos derivados de 2-(1h)-quinoleinona, su procedimiento de preparacion y composiciones farmaceuticas que los contienen. | |
IL81334A (en) | Derivatives of 2-phenyl-3-(acylaminoethyl)imidazo-(1,2-a)pyridine,their preparation and pharmaceutical compositions containing them | |
IL98987A0 (en) | Heterocyclic compounds,their preparation and their use as pesticides | |
FI865234A0 (fi) | 5-aminoalkyl- -karbolinderivat, deras framstaellning och anvaendning som laekemedel. | |
ZA894399B (en) | New derivatives of phenothiazine,their preparation and the compositions which contain them | |
KR940005596A (ko) | 알킬렌디아민 유도체 | |
DK0395527T3 (da) | Imidazobenzodiazepiner og deres salte, fremgangsmåde til deres fremstilling, deres anvendelse som lægemidler og præparater med indhold deraf | |
EP0189057A3 (en) | 5-aryl-dihydropyridines, process for their preparation as well as use in medicaments | |
ATE76398T1 (de) | 4-amino-1-trifluoromethyl-tetralin-derivate, deren herstellung und deren therapeutische verwendung. | |
KR920016425A (ko) | 이소퀴놀린 유도체 | |
EA200200462A1 (ru) | Производные 2-арилхинолина, их получение и терапевтическое применение | |
IL63513A0 (en) | Preparation of 3-(n-arylamino)-tetrahydrothiophen-2-one derivatives |